ProVascTec’s mission is to positively impact the lives of patients suffering from cardiovascular complications

ProVascTec is a preclinical stage cell therapy company, leveraging the paracrine mechanism of stem cells to induce the growth of a novel vascular system, creating a natural bypass around arterial occlusions in the peripheral vascular system, specifically below the knee. Our investigational off-the-shelf stem cells are combined with a proprietary local delivery system, suitable for integration into well established percutaneous delivery procedures

Our Team

ProVacTec is led by an experienced pharmaceutical manager and a serial inventor, embedded into the infrastructure of NLC, Europe’s largest healthtech venture builder.